Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Amylin Drops 200 Sales Reps
PharmExec, 05/11/09
Biotech firm Amylin, on Monday, announced that it would trim its sales force by 200, or about 35 percent of its total. The move is expected to save the company about $65 million by 2010, and comes on the heels of an announcement that the company asked FDA to consider a once-weekly injectable version of its Type 2 diabetes drug Byetta.
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Personalized Medicine Market To Grow 11% Annually
PharmExec, 12/16/09
Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09
Alcon to Enter Surgical Glaucoma Market by Acquiring Optonol
Alcon, 12/15/09
Article Search
Sponsor